SpringWorks Therapeutics, Inc.
SWTX
$37.06
-$0.86-2.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.60% | 9.77% | -1.06% | -17.31% | -17.19% |
| Total Depreciation and Amortization | 108.04% | 115.97% | 136.39% | 135.49% | 117.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.51% | 23.95% | 25.51% | 28.38% | 31.48% |
| Change in Net Operating Assets | -6,394.17% | -1,086.94% | -299.57% | -138.14% | -101.53% |
| Cash from Operations | 21.18% | 2.56% | -27.50% | -37.33% | -37.90% |
| Capital Expenditure | 39.73% | 90.41% | 74.69% | 53.78% | 27.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 63.73% | 28.01% | -1.95% | 71.80% | 120.52% |
| Cash from Investing | 85.72% | 32.44% | 6.00% | 70.44% | 116.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.59% | 75,287.17% | -9.17% | -10.46% | -12.46% |
| Repurchase of Common Stock | -201.36% | -220.69% | -217.96% | -211.33% | -108.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.39% | 14,307.17% | -10.84% | -12.01% | -12.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -197.88% | 96.18% | -177.15% | -23.64% | 397.87% |